Birmingham, West Midlands -- (SBWIRE) -- 01/08/2014 -- Value Penny Stocks issues special report on DURECT Corporation (NASDAQ:DRRX), Corinthian Colleges Inc (NASDAQ:COCO), Merrimack Pharmaceuticals Inc (NASDAQ:MACK).
DURECT Corporation (NASDAQ:DRRX) ended its recent business day with the gain of 5.34% and closed at the price of $1.88 after opening at $1.85. The stock traded during its last trading session with the total volume of 2,355,953 shares, as compared to its average volume of 659,345.00 shares. DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms. It focuses on the development of products for the treatment of various chronic and episodic disease areas, such as pain, central nervous system disorders, cardiovascular disease, and other chronic diseases.
For How Long DRRX will Fight for Profitability? Read This Trend Analysis report
Corinthian Colleges Inc (NASDAQ:COCO) remained among the day decliners and traded with volume of 2,321,595 shares in the last session, as compared to average volume of 1.34 million shares. In comparison with 52 week range of $1.60 - $2.97, it faced lowest price of $1.60 during the last trading session whereas its day highest price was $1.68. The company’s total market capitalization is $142.75 million, along with 87.04 million shares outstanding. Corinthian Colleges, Inc. operates as a post-secondary education company. The company offers various diploma programs, as well as associate, bachelors, and master’s degrees. It also provides training program in healthcare, criminal justice, business, mechanical, trades, and information technology areas.
Has COCO Found The Bottom And Ready To Gain Momentum? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) showed 2,313,472 shares in volume during the last trading session, while the average trading volume remained 2.51 million shares. The stock kicked off its trading session at $5.85 and closed at $5.87 after mounting 1.03%. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Continue To Move Higher? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)